{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T18:18:14Z","timestamp":1780683494087,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NHC Key Laboratory of Nuclear Technology Medical Transformation","award":["Grant no.2023HYX032"],"award-info":[{"award-number":["Grant no.2023HYX032"]}]},{"name":"Scientifc Research Project of Mianyang Health Commission","award":["Grant no. 201926"],"award-info":[{"award-number":["Grant no. 201926"]}]},{"name":"Clinical Special Project of Mianyang Central Hospital","award":["Grant No.2024LC007"],"award-info":[{"award-number":["Grant No.2024LC007"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["Grant no.82400758"],"award-info":[{"award-number":["Grant no.82400758"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Health Commission of Sichuan Province Medical Science and Technology Program","award":["Grant no.24QNMP028"],"award-info":[{"award-number":["Grant no.24QNMP028"]}]},{"name":"Medical Research Youth Innovation Project of Sichuan Province, China","award":["Grant no.Q23046"],"award-info":[{"award-number":["Grant no.Q23046"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04006-7","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T18:47:03Z","timestamp":1748371623000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Relative fat mass and risk of metabolic dysfunction associated steatotic liver disease and severe hepatic steatosis in U.S. adults: analysis of NHANES 2017\u20132020 data"],"prefix":"10.1186","volume":"25","author":[{"given":"Jianjun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianfu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghai","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Decai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"issue":"12","key":"4006_CR1","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/jama.2024.0945","volume":"331","author":"A Braillon","year":"2024","unstructured":"Braillon A. Clinical guidelines on nonalcoholic fatty liver disease. JAMA. 2024;331(12):1063.","journal-title":"JAMA"},{"issue":"9","key":"4006_CR2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, Swain MG, Congly SE, Kaplan GG, Shaheen AA. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851\u201361.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"4006_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2337\/dsi23-0010","volume":"37","author":"ZM Younossi","year":"2024","unstructured":"Younossi ZM, Henry L. Understanding the burden of nonalcoholic fatty liver disease: time for action. Diabetes Spectr. 2024;37(1):9\u201319.","journal-title":"Diabetes Spectr"},{"issue":"1 Suppl","key":"4006_CR4","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1 Suppl):S47\u201364.","journal-title":"J Hepatol"},{"issue":"12","key":"4006_CR5","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jama.2020.2298","volume":"323","author":"AC Sheka","year":"2020","unstructured":"Sheka AC, Adeyi O, Thompson J, Hameed B, Crawford PA, Ikramuddin S. Nonalcoholic steatohepatitis: A review. JAMA. 2020;323(12):1175\u201383.","journal-title":"JAMA"},{"issue":"7","key":"4006_CR6","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","volume":"158","author":"TG Cotter","year":"2020","unstructured":"Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020;158(7):1851\u201364.","journal-title":"Gastroenterology"},{"issue":"1","key":"4006_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology"},{"key":"4006_CR8","doi-asserted-by":"publisher","first-page":"17034","DOI":"10.1038\/nrdp.2017.34","volume":"3","author":"P Gonz\u00e1lez-Muniesa","year":"2017","unstructured":"Gonz\u00e1lez-Muniesa P, M\u00e1rtinez-Gonz\u00e1lez MA, Hu FB, Despr\u00e9s JP, Matsuzawa Y, Loos RJF, Moreno LA, Bray GA, Martinez JA, Obesity. Nat Rev Dis Primers. 2017;3:17034.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"4006_CR9","doi-asserted-by":"publisher","first-page":"10980","DOI":"10.1038\/s41598-018-29362-1","volume":"8","author":"OO Woolcott","year":"2018","unstructured":"Woolcott OO, Bergman RN. Relative fat mass (RFM) as a new estimator of whole-body fat percentage A cross-sectional study in American adult individuals. Sci Rep. 2018;8(1):10980.","journal-title":"Sci Rep"},{"issue":"8","key":"4006_CR10","doi-asserted-by":"publisher","first-page":"e071295","DOI":"10.1136\/bmjopen-2022-071295","volume":"13","author":"OO Woolcott","year":"2023","unstructured":"Woolcott OO, Seuring T. Temporal trends in obesity defined by the relative fat mass (RFM) index among adults in the united States from 1999 to 2020: a population-based study. BMJ Open. 2023;13(8):e071295.","journal-title":"BMJ Open"},{"issue":"1","key":"4006_CR11","doi-asserted-by":"publisher","first-page":"23496","DOI":"10.1038\/s41598-024-74635-7","volume":"14","author":"B Xiao","year":"2024","unstructured":"Xiao B, Cao C, Han Y, Hu H, He Y. Non-linear relationship between relative fat mass and diabetes risk in Japanese adults: a retrospective cohort study. Sci Rep. 2024;14(1):23496.","journal-title":"Sci Rep"},{"issue":"1","key":"4006_CR12","doi-asserted-by":"publisher","first-page":"18251","DOI":"10.1038\/s41598-024-69048-5","volume":"14","author":"L Zhao","year":"2024","unstructured":"Zhao L, Cao R, Zhang S. Association between relative fat mass and periodontitis: results from NHANES 2009\u20132014. Sci Rep. 2024;14(1):18251.","journal-title":"Sci Rep"},{"issue":"3","key":"4006_CR13","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.numecd.2023.10.034","volume":"34","author":"J Wang","year":"2024","unstructured":"Wang J, Guan J, Huang L, Li X, Huang B, Feng J, Zhang Y, Zhang J. Sex differences in the associations between relative fat mass and all-cause and cardiovascular mortality: A population-based prospective cohort study. Nutr Metab Cardiovasc Dis. 2024;34(3):738\u201354.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"4006_CR14","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.2147\/DMSO.S423272","volume":"16","author":"W Shen","year":"2023","unstructured":"Shen W, Cai L, Wang B, Wang Y, Wang N, Lu Y. Associations of relative fat mass, a novel adiposity indicator, with Non-Alcoholic fatty liver disease and cardiovascular disease: data from SPECT-China. Diabetes Metab Syndr Obes. 2023;16:2377\u201387.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"9","key":"4006_CR15","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.3390\/biomedicines11092518","volume":"11","author":"MS Lee","year":"2023","unstructured":"Lee MS, Felipe-Dimog EB, Yang JF, Chen YY, Wu KT, Kuo HJ, Lin TC, Wang CL, Hsieh MH, Lin CY, et al. The efficacy of anthropometric indicators in predicting Non-Alcoholic fatty liver disease using FibroScan\u00ae CAP values among the Taiwanese population. Biomedicines. 2023;11(9):2518.","journal-title":"Biomedicines"},{"issue":"6","key":"4006_CR16","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"PJ Eddowes","year":"2019","unstructured":"Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, Guha IN, Cobbold JF, Deeks JJ, Paradis V, et al. Accuracy of fibroscan controlled Attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(6):1717\u201330.","journal-title":"Gastroenterology"},{"key":"4006_CR17","doi-asserted-by":"publisher","first-page":"857110","DOI":"10.3389\/fendo.2022.857110","volume":"13","author":"R Xie","year":"2022","unstructured":"Xie R, Liu M. Relationship between Non-Alcoholic fatty liver disease and degree of hepatic steatosis and bone mineral density. Front Endocrinol (Lausanne). 2022;13:857110.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"4006_CR18","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","volume":"75","author":"European Association for the Study of the Liver","year":"2021","unstructured":"European Association for the Study of the Liver. Electronic address: Easloffice@easloffice.eu; clinical practice guideline panel; chair:; EASL governing board representative:; panel members:. EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis\u2013\u20092021 update. J Hepatol. 2021;75(3):659\u201389.","journal-title":"J Hepatol"},{"issue":"6","key":"4006_CR19","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1002\/hep.28394","volume":"63","author":"C Cassinotto","year":"2016","unstructured":"Cassinotto C, Boursier J, de L\u00e9dinghen V, Lebigot J, Lapuyade B, Cales P, Hiriart JB, Michalak S, Bail BL, Cartier V, et al. Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, fibroscan, and ARFI with liver biopsy. Hepatology. 2016;63(6):1817\u201327.","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"4006_CR20","first-page":"S1","volume":"59","author":"P Golabi","year":"2024","unstructured":"Golabi P, Owrangi S, Younossi ZM. Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis - prevalence, clinical impact, economic implications and management strategies. Aliment Pharmacol Ther. 2024;59(Suppl 1):S1\u20139.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"4006_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/apt.18011","volume":"60","author":"D Kim","year":"2024","unstructured":"Kim D, Wijarnpreecha K, Cholankeril G, Ahmed A. Steatotic liver disease-associated all-cause\/cause-specific mortality in the united States. Aliment Pharmacol Ther. 2024;60(1):33\u201342.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"4006_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s40001-023-01205-4","volume":"28","author":"Q Hu","year":"2023","unstructured":"Hu Q, Han K, Shen J, Sun W, Gao L, Gao Y. Association of weight-adjusted-waist index with non-alcoholic fatty liver disease and liver fibrosis: a cross-sectional study based on NHANES. Eur J Med Res. 2023;28(1):263.","journal-title":"Eur J Med Res"},{"issue":"22","key":"4006_CR23","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1001\/jama.2015.5370","volume":"313","author":"ME Rinella","year":"2015","unstructured":"Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015;313(22):2263\u201373. https:\/\/doi.org\/10.1001\/jama.2015.5370. Erratum in: JAMA. 2015;314(14):1521.","journal-title":"JAMA"},{"key":"4006_CR24","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/978-3-031-63657-8_14","volume":"1460","author":"D Yaz\u0131c\u0131","year":"2024","unstructured":"Yaz\u0131c\u0131 D, Demir S\u00c7, Sezer H. Insulin resistance, obesity, and lipotoxicity. Adv Exp Med Biol. 2024;1460:391\u2013430.","journal-title":"Adv Exp Med Biol"},{"issue":"Suppl 1Suppl 1","key":"4006_CR25","first-page":"S41","volume":"59","author":"N Noureddin","year":"2024","unstructured":"Noureddin N, Copur-Dahi N, Loomba R. Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease. Aliment Pharmacol Ther. 2024;59(Suppl 1Suppl 1):S41\u201351.","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"4006_CR26","doi-asserted-by":"publisher","first-page":"9084","DOI":"10.3390\/cimb45110570","volume":"45","author":"M Veskovi\u0107","year":"2023","unstructured":"Veskovi\u0107 M, \u0160utulovi\u0107 N, Hrn\u010di\u0107 D, Stanojlovi\u0107 O, Macut D, Mladenovi\u0107 D. The interconnection between hepatic insulin resistance and metabolic Dysfunction-Associated steatotic liver Disease-The transition from an adipocentric to liver-Centric approach. Curr Issues Mol Biol. 2023;45(11):9084\u2013102.","journal-title":"Curr Issues Mol Biol"},{"issue":"3","key":"4006_CR27","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ecl.2023.01.003","volume":"52","author":"SD Anwar","year":"2023","unstructured":"Anwar SD, Foster C, Ashraf A. Lipid disorders and Metabolic-Associated fatty liver disease. Endocrinol Metab Clin North Am. 2023;52(3):445\u201357.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"4006_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3892\/mmr.2024.13219","volume":"29","author":"FN Varra","year":"2024","unstructured":"Varra FN, Varras M, Varra VK, Theodosis-Nobelos P. Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation\u2013mediating treatment options (Review). Mol Med Rep. 2024;29(6):95.","journal-title":"Mol Med Rep"},{"issue":"6","key":"4006_CR29","doi-asserted-by":"publisher","first-page":"e13724","DOI":"10.1111\/obr.13724","volume":"25","author":"S Xu","year":"2024","unstructured":"Xu S, Lu F, Gao J, Yuan Y. Inflammation-mediated metabolic regulation in adipose tissue. Obes Rev. 2024;25(6):e13724.","journal-title":"Obes Rev"},{"key":"4006_CR30","doi-asserted-by":"publisher","first-page":"109748","DOI":"10.1016\/j.jnutbio.2024.109748","volume":"134","author":"S Xiong","year":"2024","unstructured":"Xiong S, Wang Q, Chen Y, Du H, Zhao Y. Leptin limits hepatic lipid accumulation and inflammation via vagal activation of the JAK2-STAT3\/AMPK pathway. J Nutr Biochem. 2024;134:109748.","journal-title":"J Nutr Biochem"},{"issue":"12","key":"4006_CR31","doi-asserted-by":"publisher","first-page":"6420","DOI":"10.3390\/ijms25126420","volume":"25","author":"L De la Cruz-Color","year":"2024","unstructured":"De la Cruz-Color L, Dominguez-Rosales JA, Maldonado-Gonz\u00e1lez M, Ru\u00edz-Madrigal B, S\u00e1nchez Mu\u00f1oz MP, Zaragoza-Guerra VA, Espinoza-Padilla VH, Ruelas-Cinco EDC, Ram\u00edrez-Meza SM, Torres Baranda JR, et al. Evidence that peripheral leptin resistance in omental adipose tissue and liver correlates with MASLD in humans. Int J Mol Sci. 2024;25(12):6420.","journal-title":"Int J Mol Sci"},{"key":"4006_CR32","doi-asserted-by":"publisher","first-page":"10023","DOI":"10.2147\/IJN.S478589","volume":"19","author":"J Zou","year":"2024","unstructured":"Zou J, Song Q, Shaw PC, Wu Y, Zuo Z, Yu R. Tangerine Peel-Derived Exosome-Like nanovesicles alleviate hepatic steatosis induced by type 2 diabetes: evidenced by regulating lipid metabolism and intestinal microflora. Int J Nanomed. 2024;19:10023\u201343.","journal-title":"Int J Nanomed"},{"issue":"1","key":"4006_CR33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/biom12010056","volume":"12","author":"N Vallianou","year":"2021","unstructured":"Vallianou N, Christodoulatos GS, Karampela I, Tsilingiris D, Magkos F, Stratigou T, Kounatidis D, Dalamaga M. Understanding the role of the gut Microbiome and microbial metabolites in Non-Alcoholic fatty liver disease: current evidence and perspectives. Biomolecules. 2021;12(1):56.","journal-title":"Biomolecules"},{"issue":"2","key":"4006_CR34","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/ijo.2011.100","volume":"36","author":"J G\u00f3mez-Ambrosi","year":"2012","unstructured":"G\u00f3mez-Ambrosi J, Silva C, Galofr\u00e9 JC, Escalada J, Santos S, Mill\u00e1n D, Vila N, Iba\u00f1ez P, Gil MJ, Valent\u00ed V, et al. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes (Lond). 2012;36(2):286\u201394.","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"4006_CR35","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s13098-024-01472-z","volume":"16","author":"C Cao","year":"2024","unstructured":"Cao C, Huang M, Han Y, Zhang X, Hu H, Wang Y. The nonlinear connection between relative fat mass and non-alcoholic fatty liver disease in the Japanese population: an analysis based on data from a cross-sectional study. Diabetol Metab Syndr. 2024;16(1):236.","journal-title":"Diabetol Metab Syndr"},{"issue":"5","key":"4006_CR36","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","volume":"66","author":"T Karlas","year":"2017","unstructured":"Karlas T, Petroff D, Sasso M, Fan JG, Mi YQ, de L\u00e9dinghen V, Kumar M, Lupsor-Platon M, Han KH, Cardoso AC, et al. Individual patient data meta-analysis of controlled Attenuation parameter (CAP) technology for assessing steatosis. J Hepatol. 2017;66(5):1022\u201330.","journal-title":"J Hepatol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04006-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04006-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04006-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T18:47:04Z","timestamp":1748371624000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04006-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4006"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04006-7","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The NHANES is publicly accessible, and all participants signed an informed consent form. The NHANES dataset provided by the NCHS maintains de-identification and anonymity, thus exempting investigators from obtaining duplicate ethical clearance or informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"410"}}